Moderna wins EU approval for combined flu, COVID shot for older adults

robot
Abstract generation in progress

Moderna has received marketing authorization from the European Commission for its combination vaccine designed to prevent both influenza and COVID-19. This approval is specifically for adults aged 50 years and older. The development marks a significant step in offering a single shot solution for these two respiratory viruses in the older population.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin